With an estimated one million cancer diagnoses missed across Europe in the last two years, the impact of the COVID-19 pandemic is predicted to set back European cancer outcomes... / The study also finds Brexit will continue to negatively impact European cancer research unless European funders/research community and the UK government/research community find a way for continued collaboration.

Supplies face ‘unprecedented’ disruption, yet ministers have not shared assessments with public for fear of sparking panic-buying by consumers.

A British pensioner battling an aggressive form of cancer has told of his fears for the future over health coverage for Britons in France.